发明名称 |
METHOD OF DETERMINING WHETHER A PATIENT AFFLICTED WITH CANCER CAN BE TREATED BY A THERAPEUTIC AGENT THAT TARGETS THE 17-1A ANTIGEN |
摘要 |
The present invention provides methods for identifying human cancer patients whose cancerous cells overexpress the 17-1A antigen to such an extent as determined herein that the patients may be considered as suitable for treatment with a therapeutic 17-1A antigen binding agent such as an antibody. Preferably the therapeutic antibody is Edrecolomab. Kits for use in such methods and methods of treating patients so identified are also provided.
|
申请公布号 |
US2005032133(A1) |
申请公布日期 |
2005.02.10 |
申请号 |
US20040494169 |
申请日期 |
2004.04.29 |
申请人 |
BARRATT PAULA LOUISE;CROWE JAMES SCOTT;ELLIS JONATHAN HENRY;RAPSON NICHOLAS TIMOTHY |
发明人 |
BARRATT PAULA LOUISE;CROWE JAMES SCOTT;ELLIS JONATHAN HENRY;RAPSON NICHOLAS TIMOTHY |
分类号 |
A61K45/00;A61P35/00;C07K16/30;G01N33/543;G01N33/574;(IPC1-7):G01N33/574 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|